1. Home
  2. CIVI vs TLX Comparison

CIVI vs TLX Comparison

Compare CIVI & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Civitas Resources Inc.

CIVI

Civitas Resources Inc.

N/A

Current Price

$27.19

Market Cap

2.6B

Sector

Energy

ML Signal

N/A

Logo Telix Pharmaceuticals Limited American Depositary Shares

TLX

Telix Pharmaceuticals Limited American Depositary Shares

N/A

Current Price

$8.09

Market Cap

3.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CIVI
TLX
Founded
1999
2015
Country
United States
Australia
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
3.3B
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
CIVI
TLX
Price
$27.19
$8.09
Analyst Decision
Hold
Strong Buy
Analyst Count
13
4
Target Price
$40.80
$21.00
AVG Volume (30 Days)
1.4M
165.5K
Earning Date
11-06-2025
01-15-2026
Dividend Yield
7.36%
N/A
EPS Growth
N/A
N/A
EPS
6.86
0.04
Revenue
$4,711,808,000.00
$664,225,558.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$3.96
$189.73
Revenue Growth
N/A
55.35
52 Week Low
$22.79
$7.72
52 Week High
$55.35
$30.36

Technical Indicators

Market Signals
Indicator
CIVI
TLX
Relative Strength Index (RSI) 42.21 33.56
Support Level $26.70 $7.72
Resistance Level $28.28 $10.03
Average True Range (ATR) 1.01 0.25
MACD -0.24 -0.10
Stochastic Oscillator 14.03 16.45

Price Performance

Historical Comparison
CIVI
TLX

About CIVI Civitas Resources Inc.

Civitas Resources Inc is an independent exploration and production company engaged in the acquisition, development, and production of oil and associated liquids-rich natural gas in the Rocky Mountain region, in the Denver-Julesburg Basin of Colorado - DJ Basin. The company's operations are focused on developing the horizontal Niobrara and Codell formations that have a low-cost structure, mature infrastructure, production efficiencies, multiple producing horizons, multiple service providers, established reserves, and prospective drilling opportunities.

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

Share on Social Networks: